Testing and Treating the Missing Millions with Tuberculosis

How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?: TABLE 1

(2014) Zhi Zhen Qin et al.   EUROPEAN RESPIRATORY JOURNAL

Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data

(2014) Lixia Wang et al.   LANCET

Indian government outlines plan to try to eliminate tuberculosis by 2020

(2014) S. Bagcchi   BMJ-British Medical Journal

The Importance of Implementation Strategy in Scaling Up Xpert MTB/RIF for Diagnosis of Tuberculosis in the Indian Health-Care System: A Transmission Model

(2014) Henrik Salje et al.   PLOS MEDICINE

Tuberculosis control needs a complete and patient-centric solution

(2014) Madhukar Pai et al.   Lancet Global Health

Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action

(2013) William A Wells et al.   LANCET INFECTIOUS DISEASES

Engaging the private sector to increase tuberculosis case detection: an impact evaluation study

(2012) Aamir J Khan et al.   LANCET INFECTIOUS DISEASES

Global Investments In TB Control: Economic Benefits

(2009) Ramanan Laxminarayan et al.   HEALTH AFFAIRS